ALZHEIMER'S DRUG INJUNCTION ‘UNPRINCIPLED AND UNPRECEDENTED,’ DRUGMAKER SAYS New York v. Actavis PLC | Secondary Sources | Westlaw

ALZHEIMER'S DRUG INJUNCTION ‘UNPRINCIPLED AND UNPRECEDENTED,’ DRUGMAKER SAYS New York v. Actavis PLC | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, ALZHEIMER'S DRUG INJUNCTION ‘UNPRINCIPLED AND UNPRECEDENTED,’ DRUGMAKER SAYS New York v. Actavis PLC, Secondary Sources
31 No. 2 Westlaw Journal Pharmaceutical 9
Westlaw Journal Pharmaceutical
*1 March 24, 2015
Namenda XR (Antitrust)
Copyright © 2015 Thomson Reuters .

ALZHEIMER'S DRUG INJUNCTION ‘UNPRINCIPLED AND UNPRECEDENTED,’ DRUGMAKER SAYS

New York v. Actavis PLC

Briefs and Other Related Documents
Pharmaceutical giant Actavis PLC is asking a federal appellate court to overturn a ruling requiring the company to restart production of a drug it had previously discontinued in favor of a newer “improved” version.
New York v. Actavis PLC et al., No....
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.